View of THE USE OF GLP-1 RECEPTOR AGONISTS IN IMMUNOCOMPROMISED OR IMMUNOSUPPRESSED PATIENTS

Return to Issue Details THE USE OF GLP-1 RECEPTOR AGONISTS IN IMMUNOCOMPROMISED OR IMMUNOSUPPRESSED PATIENTS Download Download PDF